KIR-favorable TCR-αβ/CD19-depleted haploidentical HCT in children with ALL/AML/MDS: primary analysis of the PTCTC ONC1401 trial
Michael A. Pulsipher(Primary Children's Hospital), Hisham Abdel‐Azim(University of Southern California), Mitchell S. Cairo(New York Medical College), Eric Anderson(University of California San Diego), Jamie L. Duke(Children's Hospital of Philadelphia), Christopher C. Dvorak(University of California, San Francisco), Wing Leung(KK Women's and Children's Hospital), Carrie L. Kitko(Vanderbilt University Medical Center), Sonali Chaudhury(Northwestern University), Julie-An Talano(Medical College of Wisconsin), Nahal Lalefar(University of California, San Francisco), Dimitrios Monos(Children's Hospital of Philadelphia), Nancy Bunin(University of Iowa), Allyson Flower(New York Medical College), Kwang Woo Ahn(Medical College of Wisconsin)
Cited by 30
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Guidelines for the Management of Pediatric and Adult Tumor Lysis Syndrome: An Evidence-Based Review
|Journal of Clinical Oncology|2008|794
NKAML: A Pilot Study to Determine the Safety and Feasibility of Haploidentical Natural Killer Cell Transplantation in Childhood Acute Myeloid Leukemia
|Journal of Clinical Oncology|2010|648